NIH roadmap for biomedical research focus of chemists at American Chemical Society meeting
PHILADELPHIA — As part of an effort to identify opportunities and gaps in biomedical research defined by the National Institutes of Health Roadmap for Medical Research, Jeremy M. Berg, director of the National Institute of General Medical Sciences, will discuss the role of chemists at the 228th national meeting of the American Chemical Society, the world’s largest scientific society.
Dr. Berg will describe how chemists can work with biologists to impact progress in medical research by participating in the NIH “roadmap” project.
The NIH Roadmap for Medical Research is a framework of priorities designed to find new pathways to discovery, stimulate interdisciplinary research teams, and reshape clinical research to accelerate medical discovery and improve health.
What: Presidential Plenary Lecture: NIH Roadmap — New Opportunities at the Chemistry-Biology Interface Where: Marriott Hotel, Liberty C When: Monday, Aug. 23, 5:30 – 6:30 p.m. Who: Jeremy M. Berg, Ph.D., Director, National Institute of General Medical Sciences of the National Institutes of Health
The American Chemical Society is a nonprofit organization, chartered by the U.S. Congress, with a multidisciplinary membership of more than 159,000 chemists and chemical engineers. It publishes numerous scientific journals and databases, convenes major research conferences and provides educational, science policy and career programs in chemistry. Its main offices are in Washington, D.C., and Columbus, Ohio.
Source: Eurekalert & othersLast reviewed: By John M. Grohol, Psy.D. on 21 Feb 2009
Published on PsychCentral.com. All rights reserved.